Titan Pharmaceuticals Stock Investor Sentiment

TTNP Stock  USD 3.65  0.01  0.27%   
Slightly above 56% of Titan Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Titan Pharmaceuticals stock suggests that many investors are alarmed at this time. Titan Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Titan Pharmaceuticals. Many technical investors use Titan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
20 hours ago at thelincolnianonline.com         
Titan Pharmaceuticals Issues Earnings Results
news
few days ago at thelincolnianonline.com         
Titan Pharmaceuticals, Inc. Short Interest Update
news
over a week ago at news.google.com         
PHIO - Phio Pharmaceuticals Corp Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over a week ago at news.google.com         
Titan Pharmaceuticals, Inc. and American Graphite Technologies Inc. Custom Reports Available on Stoc...
Google News at Macroaxis
over a week ago at news.google.com         
Titan Pharmaceuticals Coverage Initiated at StockNews.com - Defense World
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of tradable shares by Chasey Peter Louis of Titan Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Stocks in news Titan, Asian Paints, Power Grid, Nestle, Gland Pharma - The Economic Times
Google News at Macroaxis
over two months ago at thelincolnianonline.com         
Titan Pharmaceuticals Research Coverage Started at StockNews.com
news
over two months ago at news.google.com         
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep...
Google News at Macroaxis
over two months ago at news.google.com         
Titan Pharma stock hits 52-week low at 3.03 amid downturn - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Titan Pharma stock hits 52-week low at 3.20 amidst challenges - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Titan Pharma stock hits 52-week low at 3.5 amid challenges - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Titan Pharmaceuticals appoints new CEO, changes accountant - Investing.com India
Google News at Macroaxis
over three months ago at news.google.com         
Titan Pharmaceuticals Faces Double Nasdaq Compliance Challenge Over Filing, Audit Issues - StockTita...
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Mcnab James R of 200000 shares of Titan Pharmaceuticals at 0.25 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Titan Pharmaceuticals that are available to investors today. That information is available publicly through Titan media outlets and privately through word of mouth or via Titan internal channels. However, regardless of the origin, that massive amount of Titan data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Titan Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Titan Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Titan Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Titan Pharmaceuticals alpha.

Titan Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.